Summary of New Drugs in NSCLC - Paradigm shift in lung cancer treatment & a role of the pathologist

Skip to main content

New Drugs in NSCLC - Paradigm shift in lung cancer treatment & a role of the pathologist

Self enrollment

This activity has been approved for 1.0 AOA Category 2A CME credits.

Cost: 75.00
CME Expires: July 31, 2018

Category 2A

Enroll in Course